Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Basic fibroblast growth factor (bFGF), also known as FGF2, is a member of the fibroblast growth factor (FGF) family. It is a potent mitogenic and cell survival factor involved in various biological processes including embryonic development, cell proliferation, differentiation, migration, morphogenesis, tissue repair/regeneration, tumor growth/invasion, and angiogenesis. It binds to FGFRs, activating downstream signaling pathways.
bFGF exerts its effects by binding to specific fibroblast growth factor receptors (FGFRs), which are tyrosine kinase receptors. Binding activates several intracellular signaling pathways: RAS/MAPK, PI3K/AKT, PLCγ, STAT pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Basic fibroblast growth factor (bFGF).